TechTalk Blog
GenoLogics Signs Global Agreement with Pfizer

Victoria, BC, Canada – November 10, 2008 – GenoLogics, the leader in translational research informatics solutions for life sciences, today announced that it has signed a three year global agreement with Pfizer to provide informatics solutions to its research labs.

Under the terms of the agreement, GenoLogics will provide an enterprise enabled lab and data management system to capture, contextualize and integrate science data in multiple locations world wide. In addition to the ability to leverage data standards across labs by virtue of a common informatics platform, GenoLogics will provide Pfizer with the tools to enable web-based collaboration, bioinformatics pipelining, auditability and reporting of cross-science data.

“We are excited to be working with Pfizer on a global basis and supporting their research centers with informatics solutions that we can customize by lab regardless of their science,” exclaims Michael Ball, CEO of GenoLogics. “Expanding our client base to include the world’s largest pharmaceutical company is a significant milestone for GenoLogics and one that reinforces how our collaborative approach with clients ensures we deploy solutions that enable our client’s success.”

GenoLogics provides research organizations with informatics solutions from the discovery to biomedical areas, including integrated products for managing biorepositories and clinical annotations to lab and data management systems for genomics, proteomics and other sciences. The GenoLogics suite of products is developed on a common informatics platform, providing clients with a holistic solution that connects data contextually and improves the efficiency of their lab operations.

“We required a vendor that provides a highly flexible and configurable solution that can be customized for a wide range of workflows and ever-changing technologies that are employed at our research centers,” indicated Giles Day, Head, BBC Informatics at Pfizer. “The GenoLogics informatics solution can be customized at the lab level, including instrument integrations and data imports, while allowing us to analyze data across sciences and labs.”

About GenoLogics

GenoLogics provides enterprise level informatics solutions to the life sciences market that spans both the discovery and biomedical research domains. Our science purposed modules for discovery research are complemented by a highly configurable, integrating lab informatics platform that is scalable to service many labs and sciences across an organization. Our biomedical informatics product suite allows labs to track and manage their biospecimen and clinical annotations data, while aggregating results with our research informatics system for a holistic solution. For more information, please visit www.genologics.com 

Contact info:  
Bobbi Leach
Manager, Marketing Communications
GenoLogics Life Sciences Software, Inc.
250.483.7063
roberta.leach@genologics.com

Vigil Health Solutions Reports Second Quarter Results

November 10, 2008 (Victoria) – Vigil Health Solutions Inc. (“Vigil”) announces the results of operations for the quarter ending September 30, 2008.

Business highlights

• 82% growth in revenue over Q2FYE08 to $1.03 million in Q2FYE09

• 14 projects completed in the quarter compared to 9 in Q2FYE08

• 8% increase in sales bookings for the quarter to $1.16 million

• 51% growth in backlog to $4.14 million

• 54% decrease in losses to $144 thousand, or $0.001 per share

• Secured $80 thousand in National Research Council Canada Industrial Research Assistance Program (NRC-IRAP) funding for research and development of Vigil’s independent living monitoring and alerting system.

“During the second quarter, we achieved 82% year-over-year revenue growth and continued to see sales booking growth.” said Troy Griffiths, President and CEO. “While cautious in the short term given the challenging macro economic conditions, I am very encouraged by these results.”

Financial Results

Revenue for Q2FYE09 was $1.03 million compared to $568 thousand in the period ended September 30, 2007, an increase of 82%. Revenue for FYE09 to date was $1.73 million compared to $1.47 million in the first six months of FYE08, an increase of 18%. There were 22 projects completed in the period compared to 18 in the comparative period of FYE08. Bookings for the quarter were $1.16 million up 8% compared to $1.07 million in Q2FYE08. Bookings for FYE09 to date were up 17% to $2.31 million compared to $1.97 million in the first six months of FYE08.

At September 30, 2008, Vigil had a backlog of approximately $4.14 million (including $1.75 million in deposits and progress billings, recorded as deferred revenue on balance sheet) as compared to approximately $2.75 million (including $851 thousand in deposits and progress billings, recorded as deferred revenue on balance sheet) at September 30, 2007. Management recognizes that in the current financial climate there is a greater opportunity for delays or even cancellations of signed contracts.

The gross margin percentage for Q2FYE09 was 43% compared to 46% for Q2FYE08. The gross margin percentage for FYE09 to date was 44% compared to 49% for first six-months of FYE08. Gross margins are in line with management’s expectations of annual margins of between 42% and 47%. Operating expenses for Q2FYE09 were $585 thousand, up 12% from $523 thousand in the same quarter of the prior year. Operating expenses for FYE09 to date were $1.20 million up 15% from $1.05 million in the same period of the prior year. The increases relate mainly to increased payroll, insurance, and share compensation costs.

Losses for Q2FYE09 were $144 thousand, or $0.001 per share a decrease of 54% compared to $311 thousand or $0.003 per share for the previous year. The decrease in losses reflects the large increase in revenue with stable expenses as well as a foreign exchange gain in the current quarter as opposed to the $40 thousand loss in fiscal 2008. Losses for FYE09 to date were $432 thousand, or $0.004 per share an increase of 9% compared to $398 thousand or $0.004 per share for the previous year. The increase in losses can be primarily attributed to the lower revenue in the first quarter of fiscal 2009 compared to fiscal 2008.

GenoLogics Signs Global Agreement with Pfizer to provide Informatics Solutions to Multiple Research Centers

GenoLogics, the leader in translational research informatics solutions for life sciences, today announced that it has signed a three year global agreement with Pfizer to provide informatics solutions to its research labs.

 Under the terms of the agreement, GenoLogics will provide an enterprise enabled lab and data management system to capture, contextualize and integrate science data in multiple locations world wide. In addition to the ability to leverage data standards across labs by virtue of a common informatics platform, GenoLogics will provide Pfizer with the tools to enable web-based collaboration, bioinformatics pipelining, auditability and reporting of cross-science data.

“We are excited to be working with Pfizer on a global basis and supporting their research centers with informatics solutions that we can customize by lab regardless of their science,” exclaims Michael Ball, CEO of GenoLogics. “Expanding our client base to include the world’s largest pharmaceutical company is a significant milestone for GenoLogics and one that reinforces how our collaborative approach with clients ensures we deploy solutions that enable our client’s success.”

GenoLogics provides research organizations with informatics solutions from the discovery to biomedical areas, including integrated products for managing biorepositories and clinical annotations to lab and data management systems for genomics, proteomics and other sciences. The GenoLogics suite of products is developed on a common informatics platform, providing clients with a holistic solution that connects data contextually and improves the efficiency of their lab operations.

“We required a vendor that provides a highly flexible and configurable solution that can be customized for a wide range of workflows and ever-changing technologies that are employed at our research centers,” indicated Giles Day, Head, BBC Informatics at Pfizer. “The GenoLogics informatics solution can be customized at the lab level, including instrument integrations and data imports, while allowing us to analyze data across sciences and labs.”

 

About GenoLogics

GenoLogics provides enterprise level informatics solutions to the life sciences market that spans both the discovery and biomedical research domains. Our science purposed modules for discovery research are complemented by a highly configurable, integrating lab informatics platform that is scalable to service many labs and sciences across an organization. Our biomedical informatics product suite allows labs to track and manage their biospecimen and clinical annotations data, while aggregating results with our research informatics system for a holistic solution. For more information, please visit www.genologics.com

 

Contact info:  

Bobbi Leach

Manager, Marketing Communications

GenoLogics Life Sciences Software, Inc.

250.483.7063

roberta.leach@genologics.com

Zymeworks Appoints Noel Hall to Its Board of Directors

Zymeworks Inc., a privately held computational biotechnology company, today announced the appointment of Noel Hall to its board of directors. Mr. Hall’s extensive knowledge of the biotechnology industry, along with his business-building experience, will significantly contribute to Zymeworks’ growth by guiding the development of its therapeutics pipeline.

Noel Hall is a consultant to the life sciences industry with over 25 years of experience in the biotechnology sector. He was the Co-founder, President, and Director of Aspreva Pharmaceuticals, which was acquired by the Galenica Group in January 2008. Prior to Aspreva, Mr. Hall co-founded the life sciences practice of consulting firm Hill and Knowlton and served as Head of Global Strategic Planning for the firm’s worldwide pharmaceutical consulting practice. Mr. Hall was the Director of Corporate Affairs for the United Kingdom and Northern Europe for The Wellcome Foundation Ltd., which is now part of GlaxoSmithKline PLC. Additionally, Mr. Hall worked in market development with Abbott Laboratories Ltd. and was the regional sales manager with Leo Laboratories Ltd. Mr. Hall holds a B.Sc. degree in Medical Laboratory Science from London University, and currently serves on the board of directors of iCo Therapeutics Inc.

“We are extremely pleased to welcome Mr. Hall to our board of directors,” says Dr. Ali Tehrani, President and CEO of Zymeworks. “His unique combination of industry insight and experience will be a tremendous asset to Zymeworks as we continue to advance towards a protein therapeutics pipeline and expand on our strategic collaborations in the pharmaceutical and chemical sectors.”

CANTEST welcomes new Vice President of Operations

Burnaby, British Columbia – CANTEST is pleased to announce the appointment of Dr. Curtis Braun as Vice President of Operations.
     
In his role, Dr. Braun will oversee the company’s operating divisions, including Specialty Services, Bioanalytical Services, Environmental Quality, and Food Safety.  Dr. Braun will provide overall direction and guidance to the operational activities of the divisions with the objective of maximizing growth and profitability.

“I am delighted to welcome Curtis to CANTEST,” said Don Enns, President and CEO. “Curtis’s combined operational experience & technical knowledge will be advantageous as CANTEST continues to grow.”

Prior to joining CANTEST, Dr. Braun held the position of Vice President of Operations with Twinstrand Therapeutics. Dr. Braun has more than a decade of experience in the development and oversight of preclinical and clinical programs, financial management and contract negotiations. Dr. Braun obtained his PhD (Chemistry) from the University of British Columbia and received postdoctoral training in the Institute of Molecular Biology and Biochemistry at Simon Fraser University.

“As a comprehensive testing laboratory, CANTEST offers a wealth of expertise across a broad range of industries,” said Dr. Braun. “I look forward to working with all of these groups to build on our current success as we continue to expand our analytical service offerings.”

Zymeworks Appoints Noel Hall to Its Board of Directors

Zymeworks Inc., a privately held computational biotechnology company, today announced the appointment of Noel Hall to its board of directors. Mr. Hall’s extensive knowledge of the biotechnology industry, along with his business-building experience, will significantly contribute to Zymeworks’ growth by guiding the development of its therapeutics pipeline.

Noel Hall is a consultant to the life sciences industry with over 25 years of experience in the biotechnology sector. He was the Co-founder, President, and Director of Aspreva Pharmaceuticals, which was acquired by the Galenica Group in January 2008. Prior to Aspreva, Mr. Hall co-founded the life sciences practice of consulting firm Hill and Knowlton and served as Head of Global Strategic Planning for the firm’s worldwide pharmaceutical consulting practice. Mr. Hall was the Director of Corporate Affairs for the United Kingdom and Northern Europe for The Wellcome Foundation Ltd., which is now part of GlaxoSmithKline PLC. Additionally, Mr. Hall worked in market development with Abbott Laboratories Ltd. and was the regional sales manager with Leo Laboratories Ltd. Mr. Hall holds a B.Sc. degree in Medical Laboratory Science from London University, and currently serves on the board of directors of iCo Therapeutics Inc.

“We are extremely pleased to welcome Mr. Hall to our board of directors,” says Dr. Ali Tehrani, President and CEO of Zymeworks. “His unique combination of industry insight and experience will be a tremendous asset to Zymeworks as we continue to advance towards a protein therapeutics pipeline and expand on our strategic collaborations in the pharmaceutical and chemical sectors.”

ASAP Online School Administrator Program Renews Agreement with NAESP

The Accelerated School Administrator Program (ASAP), developed by Etraffic Solutions in partnership with the Council for Educational Change (CEC), has renewed their agreement with the National Association of Elementary School Principals (NAESP).  NAESP will continue to make the program available for members through their website.  ASAP provides professional development in an interactive, online format that develops school administrators into effective leaders, ready for today's challenging school environment.
 
"In today's economic climate, school districts nationwide must still provide high-quality leadership development, despite having fewer financial resources.  ASAP tools provide the solution to this dilemma.  ASAP assessments identify a candidate's areas of need and strength, while ASAP modules offer individualized learning to build on strengths and address areas of need.  ASAP's online Portfolio documents learning and builds a professional resume.  ASAP tools provide a cost effective, proactive solution to leadership preparation that helps administrators position themselves for success," notes John Juricic, Partner, Etraffic Solutions. 
 
ASAP modules were adopted by the state of Florida for online leadership preparation.  They also qualify for NAESP Continuing Education Unit credits.  Topics include communication skills, community and stakeholder relationships, parent partnerships, continuous improvement, decision-making strategies, diversity, ethical leadership, instructional leadership, human resource development, creating a learning environment and data analysis.

Fred Brown, Senior Associate Executive Director for the NAESP says, "We are committed to providing the research, tools, and learning experiences that enable our members to prepare students to be highly adaptive learners in a rapidly changing world.  ASAP continues to meet the professional development and assessment needs of principals and we are pleased to offer the program to our members."  

About Etraffic Solutions Inc.
Etraffic Solutions Inc. is one of North America's leading e-learning solutions providers, providing products and services to the education industry and a variety of corporate clients.  With a proven track record in both online and print learning models, Etraffic Solutions has the capability of delivering education and training materials on virtually any platform and in any format.  For more information, visit www.etrafficsolutions.com.
 
About The Council for Educational Change (CEC)
The Council for Educational Change is a Florida-wide, non-profit organization whose mission is to improve leadership to strengthen academic performance for all children.  CEC is a legacy organization of the Annenberg Challenge and was formerly the South Florida Annenberg Challenge.  For more information, please visit www.changeeducation.org.
 
About the NAESP
Established in 1921, the National Association of Elementary School Principals (NAESP) serves 30,000 elementary and middle school principals in the United States, Canada, and overseas.  NAESP leads in the advocacy and support for elementary and middle-level principals and other education leaders in their commitment to all children.
 
For additional information on the Accelerated School Administrator Program visit www.asapportal.com or contact:

Amanda Jorgensen
1-866-658-8238 ext. 38
ajorgensen@etrafficsolutions.com

BCIC Expands Science Fairs to Students throughout B.C.

The Science Fair Foundation of British Columbia (SFF BC) is partnering with the British Columbia Innovation Council (BCIC) to enhance and deliver The Science Fair Program across B.C.

"This new partnership expands student outreach from Kindergarten to Grade 12, significantly increasing participation in science fairs throughout the province," said Dean Rockwell, CEO, BCIC. "Through B.C.'s regional science and technology councils, BCIC will engage technology industries with local communities to increase science fair activities at all education levels."

The Science Fair Program serves as a connecting point for industry, science fair alumni, mentors, educators, and students. It supports the promotion and awareness of regional science fairs, assists teachers in the classroom, and provides opportunities for members of B.C.'s technology industries to connect with students.

"Science fairs offer students the opportunity of discovery," said Patti Leigh, Executive Director, SFF BC. "The valuable skills and experiences gained by participating in the program enable students to achieve many great successes. In British Columbia, there are numerous success stories of science fair alumni moving forward to accomplish great things."

At the young age of 30, Devon Ross is one such science fair alumni. She is a science teacher extraordinaire at Vancouver Technical Secondary School and has been recognized nationally with a Prime Minister's Award for Teaching Excellence in May 2008. Science fairs had a strong impact on her life and she hopes that her story, passion and dedication will inspire students to pursue science as she did.

"For me, science fair projects provided a unique medium for examining the world around us. I gained the confidence and passion to teach science through these new discoveries and by also having the opportunity to share my work with professors and scientists," said Ross. "I see these same revelations and sense of belonging as my students participate in science fairs. As a teacher, science fairs allow students freedom in their learning to pursue an experiment or study that interests them. This builds positive attitudes towards science and encourages active learning and creativity."

By bringing scientists into schools, hosting student career fairs, and organizing industry school tours, BCIC and SFF BC are providing students with opportunities to explore and enjoy science. This shared passion for supporting excellence in science is connecting young innovators with mentors in the science and technology fields-inspiring the next generation of leaders who will play a crucial role in B.C.'s future.

Seeker Solutions Announces the Launch of Sprout

VICTORIA, BC, Canada. – October 27, 2008 – Seeker Solutions announced today its official release of Sprout 1.0, a free, online, personalized news aggregator software that allows users to obtain the latest top news stories and blogs tailored to their individual preferences.  Seeker Solutions created Sprout to solve the challenges of trying to sift through mass amounts of information online.  As Internet users become more pressed for time, Sprout enables every user to effortlessly find news articles or blogs that are relevant to them.

Seeker Solutions’ unique relationship-based software engine that powers Sprout allows users to easily access a wide-range of content from thousands of news sources and blogs.  Once Sprout is conveniently downloaded to the user’s computer, users are able to immediately begin training their Sprout interface with their individual interests. 

Sprout is a concept created by a team of young entrepreneurs in Victoria, B.C. who had a vision of making life easier by finding maximum efficiency where people and technology come together.  In searching for a solution to information overload, Seeker Solutions has created a powerful relevancy engine that has wide-reaching applications anywhere data is overwhelming.  With Sprout, a light consumer-level infotainment product, Seeker Solutions is able to highlight the power of relevant, cross referenced results; in this case, personally relevant news and blog articles. 

“Before Sprout, using search engines or news services to obtain news that interests you required extensive searching; you had to know exactly what you wanted every time or flounder through reams of irrelevant information,” said, Duncan MacRae, founder and Director of Operations.  “With Sprout, you no longer have to do that.  You save time and only get the news you want.”

To learn more about Sprout, visit www.yoursprout.com

 

About Seeker Solutions

Seeker Solutions, Inc. is based in Victoria, B.C.  Founded in 2006, the company is developing innovative technologies that enable users to find relevant content.  The company’s search methodologies and unique cataloguing algorithms allow for truly customized searches.   For more information about the company, please visit www.seekersol.ca.  Or, contact Catherine Prestwich at cprestwich@seekersol.ca and 250-483-4129.

###

Media Contact:

Anna Vue
PR for Seeker Solutions
Phone +1 (916) 595-8157
anna@crossborderpr.com

Vigil Health Solutions and Vocollect Healthcare Systems Announce Strategic Reseller Agreement

PITTSBURGH, OCTOBER 15, 2008 – Vocollect Healthcare Systems, Inc. and Vigil Health Solutions, a leading provider of healthcare products for the long-term care industry in North America, including nurse call systems, wireless call, bed monitoring, resident check in and the award-winning Vigil Dementia System, announce an agreement where Vigil will resell AccuNurse voice-assisted care as part of its long-term care solutions offerings to its customer base.

 

AccuNurse gives caregivers the option to access resident care needs on-demand, complete documentation of care simply by talking, enhance care-team collaboration with the Silent Page capability, and track improved clinical outcomes.

 

“Communities around the country are looking for solutions that take standards of care to higher levels, provide options to manage risk, and improve staff efficiency” said Troy Griffiths, president and CEO of Vigil Health Solutions. “Voice-assisted care is a natural complement to our portfolio of emergency and nurse call solutions, enabling clients to provide a full continuum of care through the use of unobtrusive systems. The industry is demanding more homelike environments and we believe no other portfolio of solutions delivers this like Vigil plus AccuNurse.”

 

“We’re excited about our agreement with Vigil Health Solutions,” said James Quasey, president of Vocollect Healthcare Systems. “With great sensing and call technology offered by Vigil, plus personalized service with voice-assisted care, caregivers will use technology to their advantage like never before. Communities now have the tools to stay on top of resident needs, in real time, knowing caregivers have the information they need – right in their ears. By complementing their adaptable solutions with AccuNurse, we believe Vigil now offers the most advanced solution in the delivery of care, as well as opening a potentially significant new channel for revenue growth.”